Cash Flow Mankind Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
2,332.00
2,524.00
2,399.00
1,671.00
1,974.00
1,691.00
Adjustment
1,276.00
601.00
212.00
298.00
30.00
-5.00
Changes In working Capital
104.00
-146.00
-17.00
166.00
-586.00
-94.00
Cash Flow after changes in Working Capital
3,714.00
2,980.00
2,593.00
2,136.00
1,419.00
1,591.00
Cash Flow from Operating Activities
3,121.00
2,413.00
2,152.00
1,813.00
919.00
1,137.00
Cash Flow from Investing Activities
-180.00
-12,624.00
-2,080.00
-1,051.00
-1,368.00
-1,221.00
Cash Flow from Financing Activities
-2,952.00
10,232.00
5.00
-739.00
604.00
-7.00
Net Cash Inflow / Outflow
-12.00
21.00
77.00
21.00
155.00
-92.00
Opening Cash & Cash Equivalents
403.00
382.00
304.00
283.00
127.00
219.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
391.00
403.00
382.00
304.00
283.00
127.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mankind Pharma
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
2332.68
6621.1
-4,289.00
-64.77%
Adjustment
1276.52
-289.8
1,565.00
540.48%
Changes In working Capital
104.82
-2623.7
2,727.00
104.00%
Cash Flow after changes in Working Capital
3714.02
3707.6
7.00
0.17%
Cash Flow from Operating Activities
3121.29
2116.6
1,005.00
47.47%
Cash Flow from Investing Activities
-180.79
-7895.1
7,715.00
97.71%
Cash Flow from Financing Activities
-2952.69
5806.9
-8,758.00
-150.85%
Net Cash Inflow / Outflow
-12.19
28.4
-40.00
-142.92%
Opening Cash & Cash Equivalents
403.88
826.8
-423.00
-51.15%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
391.69
855.2
-464.00
-54.20%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 29.33% vs 12.12% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
3,121.29
2,413.38
29.33%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
